O	0	12	Inflammation	Inflammation	NN	B-NP
O	12	13	-	-	HYPH	O
O	13	23	modulating	modulate	VBG	B-VP
O	24	30	effect	effect	NN	B-NP
O	31	33	of	of	IN	B-PP
O	34	46	antithrombin	antithrombin	NN	B-NP
O	47	49	on	on	IN	B-PP
O	50	53	the	the	DT	B-NP
B-Tissue	54	65	endothelium	endothelium	NN	I-NP
O	65	66	.	.	.	O

O	67	75	Ligation	Ligation	NN	B-NP
O	76	78	of	of	IN	B-PP
O	79	86	heparan	heparan	NN	B-NP
O	87	94	sulfate	sulfate	NN	I-NP
O	95	108	proteoglycans	proteoglycan	NNS	I-NP
O	109	110	(	(	(	O
O	110	115	HSPGs	HSPG	NNS	B-NP
O	115	116	)	)	)	O
O	117	119	of	of	IN	B-PP
B-Tissue	120	131	endothelium	endothelium	NN	B-NP
O	132	136	with	with	IN	B-PP
O	137	149	antithrombin	antithrombin	NN	B-NP
O	150	151	(	(	(	O
O	151	153	AT	AT	NN	B-NP
O	153	154	)	)	)	O
O	155	162	induces	induce	VBZ	B-VP
B-Cell	163	171	cellular	cellular	JJ	B-NP
O	172	182	signalling	signalling	NN	I-NP
O	183	189	events	event	NNS	I-NP
O	190	194	that	that	WDT	B-NP
O	195	200	alter	alter	VBP	B-VP
O	201	204	the	the	DT	B-NP
B-Cell	205	209	cell	cell	NN	I-NP
O	209	210	'	'	POS	B-NP
O	210	211	s	s	NNS	I-NP
O	212	223	biochemical	biochemical	JJ	I-NP
O	224	227	and	and	CC	I-NP
O	228	238	functional	functional	JJ	I-NP
O	239	248	responses	response	NNS	I-NP
O	249	251	to	to	TO	B-PP
O	252	264	inflammatory	inflammatory	JJ	B-NP
O	265	272	stimuli	stimulus	NNS	I-NP
O	273	274	(	(	(	O
O	274	275	e	e	JJ	B-NP
O	275	276	.	.	.	I-NP
O	276	277	g	g	NN	I-NP
O	277	278	.	.	.	O
O	279	288	bacterial	bacterial	JJ	B-NP
O	289	307	lipopolysaccharide	lipopolysaccharide	NN	I-NP
O	308	309	[	[	(	O
O	309	312	LPS	LPS	NN	B-NP
O	312	313	]	]	)	O
O	313	314	)	)	)	O
O	314	315	.	.	.	O

O	316	323	Changes	Change	NNS	B-NP
O	324	331	include	include	VBP	B-VP
O	332	339	reduced	reduce	VBN	B-NP
O	340	347	release	release	NN	I-NP
O	348	350	of	of	IN	B-PP
O	351	363	inflammatory	inflammatory	JJ	B-NP
O	364	367	and	and	CC	I-NP
O	368	382	procoagulatory	procoagulatory	JJ	I-NP
O	383	392	mediators	mediator	NNS	I-NP
O	393	394	(	(	(	O
O	394	395	e	e	JJ	O
O	395	396	.	.	.	O
O	396	397	g	g	NN	B-NP
O	397	398	.	.	.	O
O	399	410	interleukin	interleukin	NN	B-NP
O	411	412	[	[	(	O
O	412	414	IL	IL	NN	B-NP
O	414	415	]	]	)	O
O	415	416	-	-	HYPH	B-NP
O	416	417	1	1	CD	I-NP
O	417	418	,	,	,	O
O	419	421	IL	IL	NN	B-NP
O	421	422	-	-	HYPH	O
O	422	423	6	6	CD	B-NP
O	423	424	,	,	,	O
O	425	431	tumour	tumour	NN	B-NP
O	432	440	necrosis	necrosis	NN	I-NP
O	441	447	factor	factor	NN	I-NP
O	447	448	-	-	HYPH	O
O	448	453	alpha	alpha	SYM	B-NP
O	453	454	[	[	(	O
O	454	457	TNF	TNF	NN	B-NP
O	457	458	]	]	)	O
O	458	459	)	)	)	O
O	459	460	,	,	,	O
O	461	467	tissue	tissue	NN	B-NP
O	468	474	factor	factor	NN	I-NP
O	475	476	(	(	(	O
O	476	478	TF	TF	NN	B-NP
O	478	479	)	)	)	O
O	479	480	,	,	,	O
O	481	490	adenosine	adenosine	NN	B-NP
O	491	502	diphosphate	diphosphate	NN	I-NP
O	503	504	(	(	(	O
O	504	507	ADP	ADP	NN	B-NP
O	507	508	)	)	)	O
O	509	512	and	and	CC	O
B-Cell	513	521	cellular	cellular	JJ	B-NP
O	522	530	adhesion	adhesion	NN	I-NP
O	531	540	molecules	molecule	NNS	I-NP
O	541	542	(	(	(	O
O	542	545	not	not	RB	B-VP
O	546	551	shown	show	VBN	I-VP
O	551	552	)	)	)	O
O	552	553	,	,	,	O
O	554	556	as	as	RB	B-CONJP
O	557	561	well	well	RB	I-CONJP
O	562	564	as	as	IN	I-CONJP
O	565	574	increased	increase	VBN	B-NP
O	575	582	release	release	NN	I-NP
O	583	585	of	of	IN	B-PP
O	586	601	anticoagulatory	anticoagulatory	JJ	B-NP
O	602	614	prostacyclin	prostacyclin	NN	I-NP
O	615	616	(	(	(	O
O	616	629	prostaglandin	prostaglandin	NN	B-NP
O	630	631	[	[	(	I-NP
O	631	633	PG	PG	NN	I-NP
O	633	634	]	]	)	I-NP
O	634	635	I	I	NN	I-NP
O	635	636	)	)	)	O
O	637	639	or	or	CC	O
O	640	644	CD39	CD39	NN	B-NP
O	644	645	/	/	SYM	B-NP
O	645	652	ATPDase	ATPDase	NN	I-NP
O	652	653	.	.	.	O

O	654	656	In	In	IN	B-PP
B-Tissue	657	665	neuronal	neuronal	JJ	B-NP
I-Tissue	666	672	tissue	tissue	NN	I-NP
O	672	673	,	,	,	O
O	674	684	protective	protective	JJ	B-NP
O	685	695	mechanisms	mechanism	NNS	I-NP
O	696	699	may	may	MD	B-VP
O	700	702	by	by	IN	B-PP
O	703	711	mediated	mediate	VBN	B-VP
O	712	715	via	via	IN	B-PP
O	716	719	the	the	DT	B-NP
O	720	727	release	release	NN	I-NP
O	728	730	of	of	IN	B-PP
O	731	741	calcitonin	calcitonin	NN	B-NP
O	742	746	gene	gene	NN	I-NP
O	746	747	-	-	HYPH	B-NP
O	747	754	related	relate	VBN	I-NP
O	755	762	peptide	peptide	NN	I-NP
O	763	766	and	and	CC	I-NP
O	767	773	nitric	nitric	JJ	I-NP
O	774	779	oxide	oxide	NN	I-NP
O	780	784	with	with	IN	B-PP
O	785	788	the	the	DT	B-NP
O	789	798	potential	potential	NN	I-NP
O	799	801	to	to	TO	B-VP
O	802	808	affect	affect	VB	I-VP
O	809	821	prostacyclin	prostacyclin	NN	B-NP
O	822	829	release	release	NN	I-NP
O	830	831	[	[	(	O
O	831	833	55	55	CD	B-NP
O	833	834	]	]	)	O
O	834	835	.	.	.	O

